Van Damme P - Search Results

1

Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium).

Van der Wielen M, Van Damme P, Van Herck K, Schlegel-Haueter S, Siegrist CA. Van der Wielen M, et al. Among authors: van damme p, van herck k. Vaccine. 2003 Jun 2;21(19-20):2412-7. doi: 10.1016/s0264-410x(03)00062-8. Vaccine. 2003. PMID: 12744872

2

Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors.

Van der Wielen M, Van Damme P, Chlibek R, Smetana J, von Sonnenburg F. Van der Wielen M, et al. Among authors: van damme p. Vaccine. 2006 Jun 29;24(26):5509-15. doi: 10.1016/j.vaccine.2006.04.016. Epub 2006 May 4. Vaccine. 2006. PMID: 16725234 Clinical Trial.

3

Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant.

Desombere I, Van der Wielen M, Van Damme P, Stoffel M, De Clercq N, Goilav C, Leroux-Roels G. Desombere I, et al. Among authors: van der wielen m, van damme p. Vaccine. 2002 Jun 7;20(19-20):2597-602. doi: 10.1016/s0264-410x(02)00150-0. Vaccine. 2002. PMID: 12057618 Clinical Trial.

4

Combined hepatitis A and B vaccine in elderly.

Van Damme P, Van Herck K, Van der Wielen M. Van Damme P, et al. Among authors: van der wielen m, van herck k. Vaccine. 2004 Jan 2;22(3-4):303-4. doi: 10.1016/j.vaccine.2003.08.011. Vaccine. 2004. PMID: 14670309 No abstract available.

5

A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.

Van Damme P, Van Herck K. Van Damme P, et al. Among authors: van herck k. Expert Rev Vaccines. 2004 Jun;3(3):249-67. doi: 10.1586/14760584.3.3.249. Expert Rev Vaccines. 2004. PMID: 15176942 Free article. Review.

6

Prevention of hepatitis A by Havrix: a review.

Van Herck K, Van Damme P. Van Herck K, et al. Among authors: van damme p. Expert Rev Vaccines. 2005 Aug;4(4):459-71. doi: 10.1586/14760584.4.4.459. Expert Rev Vaccines. 2005. PMID: 16117704 Free article. Review.

7

A review of the long-term protection after hepatitis A and B vaccination.

Van Damme P, Van Herck K. Van Damme P, et al. Among authors: van herck k. Travel Med Infect Dis. 2007 Mar;5(2):79-84. doi: 10.1016/j.tmaid.2006.04.004. Epub 2006 Jun 19. Travel Med Infect Dis. 2007. PMID: 17298912 Review.

8

Benefits of early hepatitis B immunization programs for newborns and infants.

Van Herck K, Van Damme P. Van Herck K, et al. Among authors: van damme p. Pediatr Infect Dis J. 2008 Oct;27(10):861-9. doi: 10.1097/INF.0b013e318173966f. Pediatr Infect Dis J. 2008. PMID: 18776823

9

Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.

Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y. Van Damme P, et al. Among authors: van der wielen m. Vaccine. 2009 Jan 14;27(3):454-9. doi: 10.1016/j.vaccine.2008.10.077. Epub 2008 Nov 18. Vaccine. 2009. PMID: 19022318 Clinical Trial.

10

Impact of rotavirus vaccination on laboratory confirmed cases in Belgium.

Hanquet G, Ducoffre G, Vergison A, Neels P, Sabbe M, Van Damme P, Van Herck K. Hanquet G, et al. Among authors: van damme p, van herck k. Vaccine. 2011 Jun 24;29(29-30):4698-703. doi: 10.1016/j.vaccine.2011.04.098. Epub 2011 May 13. Vaccine. 2011. PMID: 21571023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,251 results

Search Page

Filters